Newest Avandia study not reassuring
498994
The maker of the controversial diabetes pill Avandia on Tuesday published preliminary results of a study that the company claims show the drug does not raise heart risks. However, experts say the results are inconclusive and even seem to suggest more risk from the drug.
301160
Transplants of insulin-making cells have not lived up to the promise they showed in an initial trial.
383329
U.S. Food and Drug Administration officials are pushing for a "black box" warning of the risk of heart attack on GlaxoSmithKline Plc's diabetes drug Avandia, the Wall Street Journal reported on Wednesday, citing unnamed sources.
188930
GlaxoSmithKline's diabetes drug Avandia was not to blame for heart deaths in a trial to see if treating diabetes would reduce heart disease, U.S. government-funded researchers said on Wednesday.
40992
A new study looking at aggressive attempts to lower cholesterol in patients who had just suffered heart attacks generated a dispute yesterday as top researchers disagreed sharply over the results.
457614
One of the nation&#39;s leading cardiovascular medical researchers has issued a call for less aggressive direct-to-consumer advertising and better safety assurances of medications in a special article posted online today by JAMA because of its relevance to
534985
Early results from a new study of GlaxoSmithKline Plc's diabetes drug Avandia showed no difference in the risk of heart problems between patients taking the controversial drug and those who took other diabetes drugs, researchers said on Tuesday.
257469
Controversy over popular diabetes pill Avandia took center stage on Monday at a meeting of the world's experts on the disease, where researchers debated findings that the drug could boost heart-attack risk.
87010
New data are due out on a promising cholesterol drug. But there are doubters.
488480
RECENT press reports, which resurrected old safety concerns about nevirapine are deceptive, insincere and meant to mislead. They could not have been in the best interest of children or HIV-positive mothers.
552158
It can be incredibly difficult for patients to ferret out studies of experimental drugs that offer hope to threat their disease. There is no comprehensive database of ongoing clinical trials, but specialists offer advice for the search:
219397
NEW YORK (CBS.MW) -- Merck (MRK) is out with a statement that &quot;strongly disagrees&quot; with the findings of a new study that raised questions about the safety of its Vioxx arthritis drug.
260309
The outcome of a clinical trial that failed to show that Zetia has any medical benefits adds to concerns over the popular drug.
372654
GlaxoSmithKline yesterday trumpeted the preliminary results from a study it said found its embattled diabetes drug, Avandia , causes no more heart risks than other medications typically used by patients with diabetes .
565830
Early results from an ongoing study of GlaxoSmithKline Plc's Avandia was unable to show any increase in heart attacks among patients, but several experts said the evidence still suggests the popular diabetes drug raises the risk of heart attack.
337275
BusinessWeek Online - The news last week that GlaxoSmithKline&#39;s  popular diabetes drug Avandia may increase the risk of heart attacks is now causing a rift among doctors by specialty, leading to charges by each side that the other is endangering patients. Endocrinologists, who treat diabetics, tend to regard the data, which was published in The New England Journal of Medicine, with skepticism, pointing to weaknesses in the study, particularly when compared to more rigorous clinical trials. Cardiologists and drug safety experts, foremost among them study author Dr. ...
268173
A U.S. Food and Drug Administration  preliminary analysis found a level of heart-attack risk with  GlaxoSmithKline Plc&#39;s  diabetes drug Avandia  similar to what was reported in a study earlier this week, the  agency confirmed on Friday.